Afi Leslie Kaiyven

Afi Leslie Kaiyven

Auto-generated profile, based on publicly available information

Afi Leslie Kaiyven

University of Exeter Medical School, University of Exeter, Exeter, United Kingdom

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in The Lancet HIV
Verified
Journal Article
Closed access
OMOlivier Marcy
Olivier Marcy
MTMathurin Cyrille Tejiokem
Mathurin Cyrille Tejiokem
PMPhilippe Msellati
Philippe Msellati
KHKhanh Truong Huu
Khanh Truong Huu
VCViet Do Chau
Viet Do Chau
IFIsabelle Fournier-Nicolle
Isabelle Fournier-Nicolle

18 October 2018 in Diabetologia
Verified
Journal Article
Open access
PDF file
KLKaiyven A. Leslie
Kaiyven A. Leslie
MRMark A Russell
Mark A Russell
KTKazuto Taniguchi
Kazuto Taniguchi
SRSarah Richardson
Sarah Richardson
NMNoel Morgan
Noel Morgan
In type 1 diabetes, selective beta cell loss occurs within the inflamed milieu of insulitic islets. This milieu is generated via the enhanced secretion of proinflammatory cytokines and by the loss of anti-inflammatory molecules such as IL-4 and IL-13. While the actions of proinflammatory cytokines have been well-studied in beta cells, the effects of their anti-inflammatory counterparts have received relatively little attention and we have addressed this.

29 December 2016 in BioMed Research International
Verified
Journal Article
Open access
PDF file
FKFrancioli Koro Koro
Francioli Koro Koro
ABAlphonse Um Boock
Alphonse Um Boock
AKAfi Leslie Kaiyven
Afi Leslie Kaiyven
JNJuergen Noeske
Juergen Noeske
CGCristina Gutierrez
Cristina Gutierrez
SESara Irène Eyangoh
Sara Irène Eyangoh
Background. Cameroon this last decade continues to present a low contribution ofM. africanumandM. bovisin human tuberculosis (TB), whileM. boviswas prevalent in cattle but all these pieces of information only concerned West and Center regions.Methods. We carried out the first study in Adamaoua, one of the most rearing regions of Cameroon, on the genetic structure and drug susceptibility of the MTBC strains isolated from newly diagnosed sputum smear-positive patients aged 15 years and above. For that purpose, spoligotyping, a modified 15 standard MIRU/VNTR loci typing, and the proportion method were used.Results. Four hundred and thirty-seven MTBC isolates were analyzed by spoligotyping. Of these, 423 were identified asM. tuberculosis, within the Cameroon family being dominant with 278 (65.7%) isolates; twelve (2.75%) isolates were classified asM. africanumand two asM. bovis. MIRU/VNTR typing of the most prevalent sublineage (SIT 61) suggested that this lineage is not a unique clone as thought earlier but could constitute a group of strains implicated to different pocket of TB transmission. OnlyM. tuberculosissublineages were associated with antituberculosis drug resistance.Conclusion. These results showed the weak contribution ofM. africanumandM. bovisto human active pulmonary tuberculosis in Cameroon even in the rearing region.

10 March 2025 in Diabetes
Verified
Journal Article
Closed access
PAPouria Akhbari
Pouria Akhbari
Javier Perez-HernandezJavier Perez-Hernandez
Javier Perez-Hernandez
MRMark A. Russell
Mark A. Russell
SDShalinee Dhayal
Shalinee Dhayal
KLK. Afi Leslie
K. Afi Leslie
SRSarah Richardson
Sarah Richardson
HLA class I (HLA-I) molecules present intracellular antigenic peptides to CD8+ T cells during immune surveillance. In donors with type 1 diabetes, hyperexpression of HLA-I occurs in islets with residual insulin-producing β-cells as a hallmark of the disease. HLA-I hyperexpression is frequently detected beyond the islet boundary, forming a “halo.” We hypothesized that this halo may reflect the diffusion of soluble forms of HLA-I (sHLA-I) from the islets to the surrounding pancreatic parenchyma. To verify this, we assessed the expression of total, cell surface, and sHLA-I in β-cell lines and isolated human islets after treatment with interferon-α (IFN-α) and IFN-γ. Consistent with the expression patterns of HLA-I in situ, the β-cell lines and cultured human islets dramatically upregulated total and surface HLA-I when exposed to IFNs. Concomitantly, sHLA-I release was significantly increased. HLA-I released within extracellular vesicles and cleaved forms of HLA-I did not significantly contribute to the sHLA-I pool. Rather, IFNs upregulated mRNA splice variants lacking the transmembrane domain. Our findings suggest that β-cells respond to IFNs by upregulating cell-associated and soluble forms of HLA-I. Soluble HLA-I may play a role in modulating islet inflammation during the autoimmune attack. Article Highlights: Hyperexpression of cell-associated HLA class I (HLA-I) induced by interferons is a hallmark feature of the residual insulin-containing pancreatic islets of people with type 1 diabetes. Soluble forms of HLA-I have also been described and are increased in the blood of individuals with viral infections and autoimmune disease, including type 1 diabetes. We assessed whether β-cells release soluble HLA-I (sHLA-I) in response to interferons. We confirm that human β-cells release significant levels of sHLA-I, demonstrate that this increases after interferon exposure, and define the release mechanism. We propose that sHLA-I may affect the activity of infiltrating CD8+ T cells in type 1 diabetes.

23 October 2025 in bioRxiv
Verified
Preprint
Open access
EMEmily-Rose Martin
Emily-Rose Martin
JMJosan G. Martin
Josan G. Martin
KLKaiyven A. Leslie
Kaiyven A. Leslie
MRMark A. Russell
Mark A. Russell
AOAsami Oguro-Ando
Asami Oguro-Ando
Background: Investigating the subcellular distribution of proteins is crucial for understanding complex cell behaviours and disease mechanisms. Fluorescence microscopy is a key tool for visualising protein localisation. However, its application is often hindered by the lack of high-quality antibodies, and the common approach to overexpress recombinant fusion constructs tagged with fluorescent proteins can introduce artefacts. Endogenous protein tagging, where the sequence for a tag (typically a peptide or fluorescent protein) is integrated into the native genetic sequence encoding a protein of interest, can be used to overcome these limitations, enabling proteins to be visualised without the need for antibodies against the target protein and avoiding complications associated with recombinant protein overexpression. ORANGE (Open Resource for the Application of Neuronal Genome Editing) is a CRISPR-Cas9-based endogenous protein tagging technique which relies on homology-independent targeted integration (HITI)-mediated gene editing. Utilising HITI as the DNA repair pathway of choice gives ORANGE the advantage of being less error-prone than classical homology-directed repair (HDR)-based endogenous protein tagging techniques and additionally, means it can be used in post-mitotic cells. Results: We applied the ORANGE system to tag three proteins, CYFIP1, JAKMIP1, and STAT3, and confirmed that the expressed fusion proteins demonstrate expected subcellular localisations through fluorescence microscopy. Unexpectedly, the efficiency of ORANGE editing was less than 1% in HEK293 cells, despite high transfection efficiency. To improve the editing efficiency associated with ORANGE, we combined the ORANGE method with an established Sleeping Beauty transposase/CRISPR-Cas9 fusion technique, which has been shown to enhance HITI-mediated gene editing. Using this new method, which we term Sleeping ORANGE, we successfully tagged CYFIP1 with the fluorescent protein mNeonGreen. Importantly, through fluorescence microscopy and flow cytometry, we demonstrate that Sleeping ORANGE increased gene-editing efficiency by approximately 4- to 6-fold compared to the original ORANGE technique. Conclusions: We have developed a method to improve the editing efficiency associated with the ORANGE technique, and with further research to ensure that the fluorescent tags are correctly inserted into their target gene without off-target effects, the Sleeping ORANGE technique may form a valuable tool for researchers to use to better study protein subcellular localisation and dynamics.

10 January 2016 in British Microbiology Research Journal
Verified
Journal Article
Open access
PDF file
FKFrancioli Koro Koro
Francioli Koro Koro
JEJoseph Rodrigue Foe Essomba
Joseph Rodrigue Foe Essomba
LALeslie Kaiyven Afi
Leslie Kaiyven Afi
YSYannick Kamdem Simo
Yannick Kamdem Simo
FPFélix Fotso Piam
Félix Fotso Piam
SESara Irène Eyangoh
Sara Irène Eyangoh
Aims: Beijing remain the most M. tuberculosis lineage distributed and associated to multidrug resistance known worldwide. Its detection in a young person urge to make a large molecular epidemiology study in the concerned region since this can significantly impact tuberculosis (TB) control and vaccine strategies development. Presentation of Case: In this study, we described the first case of M. tuberculosis Beijing strain isolated from a 20 years old girl in Cameroon. This strain was resistant to Isoniazid, Rifampicin, Streptomycin and Ethambutol. Spoligotyping and MIRU/VNTR genotyping analysis showed that the strain belonged to SIT1. The patient responded well to 12 months drug therapy of 4 KmGfxPtoHCfzEZ / 8 GfxPtoCfzEZ; although she was probably contaminated by her elder sister who died from TB few months before. This case may traduce a transmission event in Cameroon. Conclusion: This was the first study that isolated M. tuberculosis Beijing lineage in Cameroon and showed the importance to purchase a large study in the concerned regions.